Point of Care Diagnostics Market - Forecast(2025 - 2031)

Report Code: HCR 40147 Report Format: PDF + Excel

Point of Care Diagnostics Market Overview:

The Point of Care Diagnostics Market size is estimated to reach $25 Billion by 2031, growing at a CAGR of 9.7% during the forecast period 2025-2031. The Point of Care Diagnostics Market is very interwoven with the global healthcare needs. The increasing prevalence of chronic and infectious diseases has driven the demand for fast and accurate diagnostic solutions. This is complemented by the growing shift towards decentralized healthcare, where POC devices enable patients and providers to run tests in a way that is not traditionally possible.  With technological advancement specifically with portable and connected devices, accuracy and accessibility of this method has improved. Furthermore, POC testing is a cost effective and time saving option for timely decision making. The demand for convenient and efficient diagnostic tools, especially for elderly patients at risk of chronic conditions, continues to drive growth.

Integration of IoT and connectivity, along with the expansion of at-home testing solutions, are the two major trends in the Point of Care (POC) market. In June 2024, Blecon introduced a ground breaking BLE technology that allows for a simplified IoT deployment without the need for device pairing. This innovation uses BLE’s advertising capability to provide secure cloud connectivity with advanced security measures, and is a scalable and low-cost solution for healthcare applications. Notably in May 2024, Watmind USA's SpeedySwab test, which is a 15 minute, at home diagnostic tool that detects COVID-19, Influenza A and B, was granted FDA Emergency Use Authorization. With this rapid, user-friendly solution, individuals can take control of their own health and help to advance decentralized healthcare.

Market Snapshot: 

Point of Care Diagnostics Market - Report Coverage:

The “Point of Care Diagnostics Market Report - Forecast (2025-2031)” by IndustryARC, covers an in-depth analysis of the following segments in the Point of Care Diagnostics Market.

Attribute Segment

By Sample Type
  • Blood
  • Urine
  • Saliva
  • Nasal, Throat & Buccal Swabs
  • Others

By Product
  • Devices
  • Reagents & Consumables
  • Software & Services

By Platform
  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Biosensors
  • Others

By Application
  • Infectious Disease Testing
  • Cardiac Markers
  • Diabetes Monitoring
  • Pregnancy Tests
  • Drug Abuse Testing
  • Lipid Panel Testing
  • Urinalysis
  • Others

By Mode of Testing
  • Prescription-based POC Testing
  • Over-the-Counter (OTC) POC Testing

By End User
  • Hospitals and Clinics
  • Home Care
  • Diagnostic Laboratories
  • Others

By Distribution Channel
  • Pharmacies & Drugstores
  • Online Pharmacies
  • Others

By Geography

  • North America (U.S., Canada and Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Netherlands, Denmark, Belgium and Rest of Europe),
  • Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Thailand and Rest of Asia-Pacific),
  • South America (Brazil, Argentina, Chile, Colombia and Rest of South America)
  • Rest of the World (Middle East and Africa).

Key Takeaways:

North America Leads the Market

North America leads the market for Point of Care Diagnostics owing to its growing incidence of chronic illnesses like diabetes, which mandate at-home treatment options. The Centre of Disease Control's (CDC) 2022 National Diabetes Statistics Report states that 37.3 million Americans or 11.3 % of the U.S. population are living with diabetes, and 28.7 million have been diagnosed with diabetes. In addition, 8.6 million people have diabetes but are not aware about it, and prediabetes affects 26.4 million people aged 65 and older which represents about half of the age group. Point of Care Diagnostics are required for effective disease management and improving the patients’ quality of life for patients with chronic conditions such as diabetes, which require regular insulin injections. The Point of Care Diagnostics market is also growing with the added support of favourable healthcare policies and insurance coverage, as it supports a large and diverse patient population dependent on convenient, accessible treatments.

Diabetes Monitoring Dominates the Market

Diabetes monitoring holds the largest share in the Point of Care Diagnostics market, owing to the rising incidence and economic burden of diabetes and the increasing diagnostic technology. By 2045, the International Diabetes Federation (IDF) estimates that approximately 1 in 8 adults, or around 783 million people, will be affected by diabetes, reflecting a 46% rise. Additionally, more than 90% of diabetes cases are classified as type 2 diabetes. The growing number of patients with diabetes makes us need better monitoring options. In July 2024, Siemens Healthineers launched the Atellica DCA Analyser, a small device that gives lab-quality HbA1c and ACR results in minutes to help doctors diagnose early and treat patients more easily. Its adaptable testing system with precise results and network connectivity solves patient care problems by speeding up medical interventions. The diabetes management segment stays strong because new technologies keep improving, while more people require better ways to handle their diabetes.

Lateral Flow Assays are Leading the Market 

Lateral Flow Assays (LFAs) lead the Point-of-Care (POC) Diagnostics market by platform, owing to their versatility, speed and accessibility. LFAs are used widely to detect antigens, antibodies and RNA and can be used to rapidly diagnose disease, including COVID-19, according to the U.S. National Institutes of Health (NIH). These are important diagnostic tests for the management and control of disease and to mitigate health crises, and especially in resource constrained settings. They are adopted widely because they are simple and can be applied to many applications. LFA efficiency is further advanced by advanced instruments such as the Axxin AX-2X-S Lateral Flow Reader, which provide high sensitivity, multiplexing and quantitative analysis. It is a fluorescence and colorimetric immunoassay device that requires minimal user input for reliable results. Its ergonomic design, networking features and compatibility with laboratory systems make it ideal for point of care and field use. The position of LFAs as the largest segment in the POC Diagnostics market is underscored by these factors, due to their rapid, cost effective and scalable diagnostic capabilities.

Rising Prevalence of Chronic Diseases Drives the Market

A major driver for the growth of the Point of Care Diagnostics Market is the rising prevalence of chronic diseases. According to the International Diabetes Federation's Diabetes Atlas, the number of people with diabetes worldwide is 10.5% of people aged 20 to 79, of whom almost half are not treated. By 2045, this number is estimated to rise by 46% and affect 783 million people. Nearly 90% of these cases are due to type 2 diabetes, which is primarily influenced by socioeconomic, demographic, environmental and genetic factors. Apart from diabetes, other long-term diseases such as cardiovascular diseases are also driving the demand for efficient and easily accessible healthcare solutions. With the growing number of people with chronic conditions that need ongoing management, the demand for convenient, rapid and accurate diagnostic tools at home or in care settings is increasing. The expansion of the Point of Care market is driven by this shift towards more accessible and user-friendly healthcare options.


 Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the Point of Care Diagnostics Market. The top 10 companies in this industry are listed below:
1.    Abbott Laboratories
2.    Siemens Healthineers AG
3.    F. Hoffmann-La Roche Ltd.
4.    Danaher Corporation
5.    Becton, Dickinson and Company
6.    QuidelOrtho Corporation
7.    Thermo Fisher Scientific Inc.
8.    bioMérieux SA
9.    EKF Diagnostics Holdings plc
10.    Trinity biotech plc

Scope of the Report: 

Report Metric Details

Base Year Considered

2024

Forecast Period

2025–2031

CAGR

9.7%

Market Size in 2031

$25 Billion

Segments Covered

By Sample Type, By Product, By Platform, By Application, By Mode of Testing, By End User, By Distribution Channel and By Geography.

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Netherlands, Denmark, Belgium and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Thailand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players
  1. Abbott Laboratories
  2. Siemens Healthineers AG
  3. F. Hoffmann-La Roche Ltd.
  4. Danaher Corporation
  5. Becton, Dickinson and Company
  6. QuidelOrtho Corporation
  7. Thermo Fisher Scientific Inc.
  8. bioMérieux SA
  9. EKF Diagnostics Holdings plc
  10. Trinity biotech plc

 

For more Lifesciences and Healthcare Market reports, please click here

  
1.    Point of Care Diagnostics Market - Overview
      1.1.    Definitions and Scope
  2.    Point of Care Diagnostics Market - Executive Summary
      2.1.    Key trends by Sample Type
      2.2.    Key trends by Product
      2.3.    Key trends by Platform
      2.4.    Key trends by Application
      2.5.    Key trends by Mode of Testing
      2.6.    Key trends by End User
      2.7.    Key trends by Distribution Channel
      2.8.    Key trends by Geography
  3.    Point of Care Diagnostics Market - Comparative Analysis
      3.1.    Company Benchmarking - Key Companies
      3.2.    Financial Analysis - Key Companies
      3.3.    Market Share Analysis - Key Companies
      3.4.    Patent Analysis
      3.5.    Pricing Analysis
  4.    Point of Care Diagnostics Market - Start-up Companies Scenario
      4.1.    Key Start-up Company Analysis by
            4.1.1.    Investment & Revenue
            4.1.2.    Venture Capital and Funding Scenario
  5.    Point of Care Diagnostics Market – Market Entry Scenario Premium
      5.1.    Regulatory Framework Overview
      5.2.    New Business and Ease of Doing Business Index
      5.3.    Case Studies of Successful Ventures
  6.    Point of Care Diagnostics Market - Forces
      6.1.    Market Drivers
      6.2.    Market Constraints
      6.3.    Market Challenges
      6.4.    Porter's Five Force Model
            6.4.1.    Bargaining Power of Suppliers
            6.4.2.    Bargaining Powers of Customers
            6.4.3.    Threat of New Entrants
            6.4.4.    Rivalry Among Existing Players
            6.4.5.    Threat of Substitutes
  7.    Point of Care Diagnostics Market – Strategic Analysis
      7.1.    Value Chain Analysis
      7.2.    Opportunities Analysis
      7.3.    Product Life Cycle/Market Life Cycle Analysis
      7.4.    Supplier/Distributor Analysis
  8.    Point of Care Diagnostics Market – By Sample Type (Market Size – $Million/$Billion)
      8.1.    Blood
      8.2.    Urine
      8.3.    Saliva
      8.4.    Nasal, Throat & Buccal Swabs
      8.5.    Others
  9.    Point of Care Diagnostics Market – By Product (Market Size – $Million/$Billion)
      9.1.    Devices
            9.1.1.    Analyzers
            9.1.2.    Handheld Devices
            9.1.3.    Others
      9.2.    Reagents & Consumables
            9.2.1.    Test Strips
            9.2.2.    Cartridges
            9.2.3.    Assays
            9.2.4.    Kits
            9.2.5.    Others
      9.3.    Software & Services
  10.    Point of Care Diagnostics Market – By Platform (Market Size – $Million/$Billion)
      10.1.    Lateral Flow Assays
      10.2.    Dipsticks
      10.3.    Microfluidics
      10.4.    Molecular Diagnostics
      10.5.    Immunoassays
      10.6.    Biosensors
      10.7.    Others
  11.    Point of Care Diagnostics Market– By Application (Market Size – $Million/$Billion)
      11.1.    Infectious Disease Testing
            11.1.1.    COVID-19
            11.1.2.    HIV
            11.1.3.    Tuberculosis
            11.1.4.    Hepatitis
            11.1.5.    Others
      11.2.    Cardiac Markers
            11.2.1.    D-Dimer
            11.2.2.    BNP
            11.2.3.    Troponin
            11.2.4.    Others
      11.3.    Diabetes Monitoring
      11.4.    Pregnancy Tests
      11.5.    Drug Abuse Testing
      11.6.    Lipid Panel Testing
      11.7.    Urinalysis
      11.8.    Others
  12.    Point of Care Diagnostics Market– By Mode of Testing (Market Size – $Million/$Billion)
      12.1.    Prescription-based POC Testing 
      12.2.    Over-the-Counter (OTC) POC Testing
  13.    Point of Care Diagnostics Market– By End User (Market Size – $Million/$Billion)
      13.1.    Hospitals and Clinics
      13.2.    Home Care
      13.3.    Diagnostic Laboratories
      13.4.    Others
  14.    Point of Care Diagnostics Market– By Distribution Channel (Market Size – $Million/$Billion)
      14.1.    Pharmacies & Drugstores
      14.2.    Online Pharmacies
      14.3.    Others
  15.    Point of Care Diagnostics Market – by Geography (Market Size – $Million/$Billion) 
      15.1.    North America
            15.1.1.    U.S
            15.1.2.    Canada
            15.1.3.    Mexico
      15.2.    Europe
            15.2.1.    Germany
            15.2.2.    France
            15.2.3.    UK
            15.2.4.    Italy
            15.2.5.    Spain
            15.2.6.    Netherlands
            15.2.7.    Denmark
            15.2.8.    Belgium
            15.2.9.    Rest of Europe
      15.3.    Asia-Pacific
            15.3.1.    China
            15.3.2.    Japan
            15.3.3.    South Korea
            15.3.4.    India
            15.3.5.    Australia & New Zealand
            15.3.6.    Indonesia
            15.3.7.    Malaysia
            15.3.8.    Thailand
            15.3.9.    Rest of Asia-Pacific
      15.4.     South America
            15.4.1.    Brazil
            15.4.2.    Argentina
            15.4.3.    Chile
            15.4.4.    Colombia
            15.4.5.    Rest of South America
      15.5.    Rest of The World
            15.5.1.    Middle East
            15.5.2.    Africa
  16.    Point of Care Diagnostics Market – Entropy
      16.1.    New product launches
      16.2.    M&A's, collaborations, JVs and partnerships
  17.    Point of Care Diagnostics Market – Industry/Segment Competition Landscape 
      17.1.    Market Share Analysis
            17.1.1.    Market Share by Global 
            17.1.2.    Market Share by Region
            17.1.3.    Market Share by Country
  18.    Point of Care Diagnostics Market – Key Company List by Country Premium 
  19.    Point of Care Diagnostics Market – Company Analysis
      19.1.    Abbott Laboratories
      19.2.    Siemens Healthineers AG
      19.3.    F. Hoffmann-La Roche Ltd.
      19.4.    Danaher Corporation
      19.5.    Becton, Dickinson and Company
      19.6.    QuidelOrtho Corporation
      19.7.    Thermo Fisher Scientific Inc.
      19.8.    bioMérieux SA
      19.9.    EKF Diagnostics Holdings plc
      19.10.    Trinity biotech plc
  "Financials to the Private Companies would be provided on a best-effort basis."
  Connect with our experts to get customized reports that best suit your requirements. Our 
  reports include global-level data, niche markets, and competitive landscape.
   

LIST OF TABLES

1.Global Point-Of-Care Diagnostics Market, By Product Market 2023-2030 ($M)
1.1 Glucose Monitoring Product Market 2023-2030 ($M) - Global Industry Research
1.1.1 Strip Market 2023-2030 ($M)
1.1.2 Meter Market 2023-2030 ($M)
1.1.3 Lancet & Lancing Device Market 2023-2030 ($M)
1.2 Cardiometabolic Testing Product Market 2023-2030 ($M) - Global Industry Research
1.2.1 Cardiac Marker Testing Product Market 2023-2030 ($M)
1.2.2 Blood Gas/Electrolytes Testing Product Market 2023-2030 ($M)
1.2.3 Hba1C Testing Product Market 2023-2030 ($M)
1.3 Infectious Disease Testing Product Market 2023-2030 ($M) - Global Industry Research
1.3.1 Influenza Testing Product Market 2023-2030 ($M)
1.3.2 Hiv Testing Product Market 2023-2030 ($M)
1.3.3 Hepatitis C Testing Product Market 2023-2030 ($M)
1.3.4 Sexually Transmitted Disease Testing Product Market 2023-2030 ($M)
1.3.5 Healthcare-Associated Infection Testing Product Market 2023-2030 ($M)
1.3.6 Respiratory Infection Testing Product Market 2023-2030 ($M)
1.3.7 Tropical Disease Testing Product Market 2023-2030 ($M)
1.4 Coagulation Testing Product Market 2023-2030 ($M) - Global Industry Research
1.4.1 Pt/Inr Testing Product Market 2023-2030 ($M)
1.4.2 Activated Clotting Time Testing Product Market 2023-2030 ($M)
1.5 Pregnancy And Fertility Testing Product Market 2023-2030 ($M) - Global Industry Research
1.5.1 Pregnancy Testing Product Market 2023-2030 ($M)
1.5.2 Fertility Testing Product Market 2023-2030 ($M)
1.6 Tumor/Cancer Marker Testing Product Market 2023-2030 ($M) - Global Industry Research
1.7 Urinalysis Testing Product Market 2023-2030 ($M) - Global Industry Research
1.8 Cholesterol Testing Product Market 2023-2030 ($M) - Global Industry Research
1.9 Hematology Testing Product Market 2023-2030 ($M) - Global Industry Research
1.10 Drugs-Of-Abuse Testing Product Market 2023-2030 ($M) - Global Industry Research
1.11 Fecal Occult Testing Product Market 2023-2030 ($M) - Global Industry Research
2.Global Point-Of-Care Diagnostics Market, By Platform Market 2023-2030 ($M)
2.1 Lateral Flow Assay Market 2023-2030 ($M) - Global Industry Research
2.2 Dipstick Market 2023-2030 ($M) - Global Industry Research
2.3 Microfluidics Market 2023-2030 ($M) - Global Industry Research
2.4 Molecular Diagnostics Market 2023-2030 ($M) - Global Industry Research
2.5 Immunoassay Market 2023-2030 ($M) - Global Industry Research
3.Global Point-Of-Care Diagnostics Market, By Prescription Mode Market 2023-2030 ($M)
3.1 Prescription-Based Testing Market 2023-2030 ($M) - Global Industry Research
3.2 Otc Testing Market 2023-2030 ($M) - Global Industry Research
4.Global Point-Of-Care Diagnostics Market, By End User Market 2023-2030 ($M)
4.1 Professional Diagnostic Center Market 2023-2030 ($M) - Global Industry Research
4.1.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Setting Market 2023-2030 ($M)
4.1.2 Hospitals/Critical Care Center Market 2023-2030 ($M)
4.2 Home Care Market 2023-2030 ($M) - Global Industry Research
4.3 Research Laboratory Market 2023-2030 ($M) - Global Industry Research
5.Global Point-Of-Care Diagnostics Market, By Product Market 2023-2030 (Volume/Units)
5.1 Glucose Monitoring Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.1.1 Strip Market 2023-2030 (Volume/Units)
5.1.2 Meter Market 2023-2030 (Volume/Units)
5.1.3 Lancet & Lancing Device Market 2023-2030 (Volume/Units)
5.2 Cardiometabolic Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.2.1 Cardiac Marker Testing Product Market 2023-2030 (Volume/Units)
5.2.2 Blood Gas/Electrolytes Testing Product Market 2023-2030 (Volume/Units)
5.2.3 Hba1C Testing Product Market 2023-2030 (Volume/Units)
5.3 Infectious Disease Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.3.1 Influenza Testing Product Market 2023-2030 (Volume/Units)
5.3.2 Hiv Testing Product Market 2023-2030 (Volume/Units)
5.3.3 Hepatitis C Testing Product Market 2023-2030 (Volume/Units)
5.3.4 Sexually Transmitted Disease Testing Product Market 2023-2030 (Volume/Units)
5.3.5 Healthcare-Associated Infection Testing Product Market 2023-2030 (Volume/Units)
5.3.6 Respiratory Infection Testing Product Market 2023-2030 (Volume/Units)
5.3.7 Tropical Disease Testing Product Market 2023-2030 (Volume/Units)
5.4 Coagulation Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.4.1 Pt/Inr Testing Product Market 2023-2030 (Volume/Units)
5.4.2 Activated Clotting Time Testing Product Market 2023-2030 (Volume/Units)
5.5 Pregnancy And Fertility Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.5.1 Pregnancy Testing Product Market 2023-2030 (Volume/Units)
5.5.2 Fertility Testing Product Market 2023-2030 (Volume/Units)
5.6 Tumor/Cancer Marker Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.7 Urinalysis Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.8 Cholesterol Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.9 Hematology Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.10 Drugs-Of-Abuse Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
5.11 Fecal Occult Testing Product Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Point-Of-Care Diagnostics Market, By Platform Market 2023-2030 (Volume/Units)
6.1 Lateral Flow Assay Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Dipstick Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Microfluidics Market 2023-2030 (Volume/Units) - Global Industry Research
6.4 Molecular Diagnostics Market 2023-2030 (Volume/Units) - Global Industry Research
6.5 Immunoassay Market 2023-2030 (Volume/Units) - Global Industry Research
7.Global Point-Of-Care Diagnostics Market, By Prescription Mode Market 2023-2030 (Volume/Units)
7.1 Prescription-Based Testing Market 2023-2030 (Volume/Units) - Global Industry Research
7.2 Otc Testing Market 2023-2030 (Volume/Units) - Global Industry Research
8.Global Point-Of-Care Diagnostics Market, By End User Market 2023-2030 (Volume/Units)
8.1 Professional Diagnostic Center Market 2023-2030 (Volume/Units) - Global Industry Research
8.1.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Setting Market 2023-2030 (Volume/Units)
8.1.2 Hospitals/Critical Care Center Market 2023-2030 (Volume/Units)
8.2 Home Care Market 2023-2030 (Volume/Units) - Global Industry Research
8.3 Research Laboratory Market 2023-2030 (Volume/Units) - Global Industry Research
9.North America Point-Of-Care Diagnostics Market, By Product Market 2023-2030 ($M)
9.1 Glucose Monitoring Product Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Strip Market 2023-2030 ($M)
9.1.2 Meter Market 2023-2030 ($M)
9.1.3 Lancet & Lancing Device Market 2023-2030 ($M)
9.2 Cardiometabolic Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Cardiac Marker Testing Product Market 2023-2030 ($M)
9.2.2 Blood Gas/Electrolytes Testing Product Market 2023-2030 ($M)
9.2.3 Hba1C Testing Product Market 2023-2030 ($M)
9.3 Infectious Disease Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.3.1 Influenza Testing Product Market 2023-2030 ($M)
9.3.2 Hiv Testing Product Market 2023-2030 ($M)
9.3.3 Hepatitis C Testing Product Market 2023-2030 ($M)
9.3.4 Sexually Transmitted Disease Testing Product Market 2023-2030 ($M)
9.3.5 Healthcare-Associated Infection Testing Product Market 2023-2030 ($M)
9.3.6 Respiratory Infection Testing Product Market 2023-2030 ($M)
9.3.7 Tropical Disease Testing Product Market 2023-2030 ($M)
9.4 Coagulation Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.4.1 Pt/Inr Testing Product Market 2023-2030 ($M)
9.4.2 Activated Clotting Time Testing Product Market 2023-2030 ($M)
9.5 Pregnancy And Fertility Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.5.1 Pregnancy Testing Product Market 2023-2030 ($M)
9.5.2 Fertility Testing Product Market 2023-2030 ($M)
9.6 Tumor/Cancer Marker Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.7 Urinalysis Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.8 Cholesterol Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.9 Hematology Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.10 Drugs-Of-Abuse Testing Product Market 2023-2030 ($M) - Regional Industry Research
9.11 Fecal Occult Testing Product Market 2023-2030 ($M) - Regional Industry Research
10.North America Point-Of-Care Diagnostics Market, By Platform Market 2023-2030 ($M)
10.1 Lateral Flow Assay Market 2023-2030 ($M) - Regional Industry Research
10.2 Dipstick Market 2023-2030 ($M) - Regional Industry Research
10.3 Microfluidics Market 2023-2030 ($M) - Regional Industry Research
10.4 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
10.5 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
11.North America Point-Of-Care Diagnostics Market, By Prescription Mode Market 2023-2030 ($M)
11.1 Prescription-Based Testing Market 2023-2030 ($M) - Regional Industry Research
11.2 Otc Testing Market 2023-2030 ($M) - Regional Industry Research
12.North America Point-Of-Care Diagnostics Market, By End User Market 2023-2030 ($M)
12.1 Professional Diagnostic Center Market 2023-2030 ($M) - Regional Industry Research
12.1.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Setting Market 2023-2030 ($M)
12.1.2 Hospitals/Critical Care Center Market 2023-2030 ($M)
12.2 Home Care Market 2023-2030 ($M) - Regional Industry Research
12.3 Research Laboratory Market 2023-2030 ($M) - Regional Industry Research
13.South America Point-Of-Care Diagnostics Market, By Product Market 2023-2030 ($M)
13.1 Glucose Monitoring Product Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Strip Market 2023-2030 ($M)
13.1.2 Meter Market 2023-2030 ($M)
13.1.3 Lancet & Lancing Device Market 2023-2030 ($M)
13.2 Cardiometabolic Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Cardiac Marker Testing Product Market 2023-2030 ($M)
13.2.2 Blood Gas/Electrolytes Testing Product Market 2023-2030 ($M)
13.2.3 Hba1C Testing Product Market 2023-2030 ($M)
13.3 Infectious Disease Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.3.1 Influenza Testing Product Market 2023-2030 ($M)
13.3.2 Hiv Testing Product Market 2023-2030 ($M)
13.3.3 Hepatitis C Testing Product Market 2023-2030 ($M)
13.3.4 Sexually Transmitted Disease Testing Product Market 2023-2030 ($M)
13.3.5 Healthcare-Associated Infection Testing Product Market 2023-2030 ($M)
13.3.6 Respiratory Infection Testing Product Market 2023-2030 ($M)
13.3.7 Tropical Disease Testing Product Market 2023-2030 ($M)
13.4 Coagulation Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.4.1 Pt/Inr Testing Product Market 2023-2030 ($M)
13.4.2 Activated Clotting Time Testing Product Market 2023-2030 ($M)
13.5 Pregnancy And Fertility Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.5.1 Pregnancy Testing Product Market 2023-2030 ($M)
13.5.2 Fertility Testing Product Market 2023-2030 ($M)
13.6 Tumor/Cancer Marker Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.7 Urinalysis Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.8 Cholesterol Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.9 Hematology Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.10 Drugs-Of-Abuse Testing Product Market 2023-2030 ($M) - Regional Industry Research
13.11 Fecal Occult Testing Product Market 2023-2030 ($M) - Regional Industry Research
14.South America Point-Of-Care Diagnostics Market, By Platform Market 2023-2030 ($M)
14.1 Lateral Flow Assay Market 2023-2030 ($M) - Regional Industry Research
14.2 Dipstick Market 2023-2030 ($M) - Regional Industry Research
14.3 Microfluidics Market 2023-2030 ($M) - Regional Industry Research
14.4 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
14.5 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
15.South America Point-Of-Care Diagnostics Market, By Prescription Mode Market 2023-2030 ($M)
15.1 Prescription-Based Testing Market 2023-2030 ($M) - Regional Industry Research
15.2 Otc Testing Market 2023-2030 ($M) - Regional Industry Research
16.South America Point-Of-Care Diagnostics Market, By End User Market 2023-2030 ($M)
16.1 Professional Diagnostic Center Market 2023-2030 ($M) - Regional Industry Research
16.1.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Setting Market 2023-2030 ($M)
16.1.2 Hospitals/Critical Care Center Market 2023-2030 ($M)
16.2 Home Care Market 2023-2030 ($M) - Regional Industry Research
16.3 Research Laboratory Market 2023-2030 ($M) - Regional Industry Research
17.Europe Point-Of-Care Diagnostics Market, By Product Market 2023-2030 ($M)
17.1 Glucose Monitoring Product Market 2023-2030 ($M) - Regional Industry Research
17.1.1 Strip Market 2023-2030 ($M)
17.1.2 Meter Market 2023-2030 ($M)
17.1.3 Lancet & Lancing Device Market 2023-2030 ($M)
17.2 Cardiometabolic Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.2.1 Cardiac Marker Testing Product Market 2023-2030 ($M)
17.2.2 Blood Gas/Electrolytes Testing Product Market 2023-2030 ($M)
17.2.3 Hba1C Testing Product Market 2023-2030 ($M)
17.3 Infectious Disease Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.3.1 Influenza Testing Product Market 2023-2030 ($M)
17.3.2 Hiv Testing Product Market 2023-2030 ($M)
17.3.3 Hepatitis C Testing Product Market 2023-2030 ($M)
17.3.4 Sexually Transmitted Disease Testing Product Market 2023-2030 ($M)
17.3.5 Healthcare-Associated Infection Testing Product Market 2023-2030 ($M)
17.3.6 Respiratory Infection Testing Product Market 2023-2030 ($M)
17.3.7 Tropical Disease Testing Product Market 2023-2030 ($M)
17.4 Coagulation Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.4.1 Pt/Inr Testing Product Market 2023-2030 ($M)
17.4.2 Activated Clotting Time Testing Product Market 2023-2030 ($M)
17.5 Pregnancy And Fertility Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.5.1 Pregnancy Testing Product Market 2023-2030 ($M)
17.5.2 Fertility Testing Product Market 2023-2030 ($M)
17.6 Tumor/Cancer Marker Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.7 Urinalysis Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.8 Cholesterol Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.9 Hematology Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.10 Drugs-Of-Abuse Testing Product Market 2023-2030 ($M) - Regional Industry Research
17.11 Fecal Occult Testing Product Market 2023-2030 ($M) - Regional Industry Research
18.Europe Point-Of-Care Diagnostics Market, By Platform Market 2023-2030 ($M)
18.1 Lateral Flow Assay Market 2023-2030 ($M) - Regional Industry Research
18.2 Dipstick Market 2023-2030 ($M) - Regional Industry Research
18.3 Microfluidics Market 2023-2030 ($M) - Regional Industry Research
18.4 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
18.5 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
19.Europe Point-Of-Care Diagnostics Market, By Prescription Mode Market 2023-2030 ($M)
19.1 Prescription-Based Testing Market 2023-2030 ($M) - Regional Industry Research
19.2 Otc Testing Market 2023-2030 ($M) - Regional Industry Research
20.Europe Point-Of-Care Diagnostics Market, By End User Market 2023-2030 ($M)
20.1 Professional Diagnostic Center Market 2023-2030 ($M) - Regional Industry Research
20.1.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Setting Market 2023-2030 ($M)
20.1.2 Hospitals/Critical Care Center Market 2023-2030 ($M)
20.2 Home Care Market 2023-2030 ($M) - Regional Industry Research
20.3 Research Laboratory Market 2023-2030 ($M) - Regional Industry Research
21.APAC Point-Of-Care Diagnostics Market, By Product Market 2023-2030 ($M)
21.1 Glucose Monitoring Product Market 2023-2030 ($M) - Regional Industry Research
21.1.1 Strip Market 2023-2030 ($M)
21.1.2 Meter Market 2023-2030 ($M)
21.1.3 Lancet & Lancing Device Market 2023-2030 ($M)
21.2 Cardiometabolic Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.2.1 Cardiac Marker Testing Product Market 2023-2030 ($M)
21.2.2 Blood Gas/Electrolytes Testing Product Market 2023-2030 ($M)
21.2.3 Hba1C Testing Product Market 2023-2030 ($M)
21.3 Infectious Disease Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.3.1 Influenza Testing Product Market 2023-2030 ($M)
21.3.2 Hiv Testing Product Market 2023-2030 ($M)
21.3.3 Hepatitis C Testing Product Market 2023-2030 ($M)
21.3.4 Sexually Transmitted Disease Testing Product Market 2023-2030 ($M)
21.3.5 Healthcare-Associated Infection Testing Product Market 2023-2030 ($M)
21.3.6 Respiratory Infection Testing Product Market 2023-2030 ($M)
21.3.7 Tropical Disease Testing Product Market 2023-2030 ($M)
21.4 Coagulation Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.4.1 Pt/Inr Testing Product Market 2023-2030 ($M)
21.4.2 Activated Clotting Time Testing Product Market 2023-2030 ($M)
21.5 Pregnancy And Fertility Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.5.1 Pregnancy Testing Product Market 2023-2030 ($M)
21.5.2 Fertility Testing Product Market 2023-2030 ($M)
21.6 Tumor/Cancer Marker Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.7 Urinalysis Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.8 Cholesterol Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.9 Hematology Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.10 Drugs-Of-Abuse Testing Product Market 2023-2030 ($M) - Regional Industry Research
21.11 Fecal Occult Testing Product Market 2023-2030 ($M) - Regional Industry Research
22.APAC Point-Of-Care Diagnostics Market, By Platform Market 2023-2030 ($M)
22.1 Lateral Flow Assay Market 2023-2030 ($M) - Regional Industry Research
22.2 Dipstick Market 2023-2030 ($M) - Regional Industry Research
22.3 Microfluidics Market 2023-2030 ($M) - Regional Industry Research
22.4 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
22.5 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
23.APAC Point-Of-Care Diagnostics Market, By Prescription Mode Market 2023-2030 ($M)
23.1 Prescription-Based Testing Market 2023-2030 ($M) - Regional Industry Research
23.2 Otc Testing Market 2023-2030 ($M) - Regional Industry Research
24.APAC Point-Of-Care Diagnostics Market, By End User Market 2023-2030 ($M)
24.1 Professional Diagnostic Center Market 2023-2030 ($M) - Regional Industry Research
24.1.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Setting Market 2023-2030 ($M)
24.1.2 Hospitals/Critical Care Center Market 2023-2030 ($M)
24.2 Home Care Market 2023-2030 ($M) - Regional Industry Research
24.3 Research Laboratory Market 2023-2030 ($M) - Regional Industry Research
25.MENA Point-Of-Care Diagnostics Market, By Product Market 2023-2030 ($M)
25.1 Glucose Monitoring Product Market 2023-2030 ($M) - Regional Industry Research
25.1.1 Strip Market 2023-2030 ($M)
25.1.2 Meter Market 2023-2030 ($M)
25.1.3 Lancet & Lancing Device Market 2023-2030 ($M)
25.2 Cardiometabolic Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.2.1 Cardiac Marker Testing Product Market 2023-2030 ($M)
25.2.2 Blood Gas/Electrolytes Testing Product Market 2023-2030 ($M)
25.2.3 Hba1C Testing Product Market 2023-2030 ($M)
25.3 Infectious Disease Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.3.1 Influenza Testing Product Market 2023-2030 ($M)
25.3.2 Hiv Testing Product Market 2023-2030 ($M)
25.3.3 Hepatitis C Testing Product Market 2023-2030 ($M)
25.3.4 Sexually Transmitted Disease Testing Product Market 2023-2030 ($M)
25.3.5 Healthcare-Associated Infection Testing Product Market 2023-2030 ($M)
25.3.6 Respiratory Infection Testing Product Market 2023-2030 ($M)
25.3.7 Tropical Disease Testing Product Market 2023-2030 ($M)
25.4 Coagulation Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.4.1 Pt/Inr Testing Product Market 2023-2030 ($M)
25.4.2 Activated Clotting Time Testing Product Market 2023-2030 ($M)
25.5 Pregnancy And Fertility Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.5.1 Pregnancy Testing Product Market 2023-2030 ($M)
25.5.2 Fertility Testing Product Market 2023-2030 ($M)
25.6 Tumor/Cancer Marker Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.7 Urinalysis Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.8 Cholesterol Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.9 Hematology Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.10 Drugs-Of-Abuse Testing Product Market 2023-2030 ($M) - Regional Industry Research
25.11 Fecal Occult Testing Product Market 2023-2030 ($M) - Regional Industry Research
26.MENA Point-Of-Care Diagnostics Market, By Platform Market 2023-2030 ($M)
26.1 Lateral Flow Assay Market 2023-2030 ($M) - Regional Industry Research
26.2 Dipstick Market 2023-2030 ($M) - Regional Industry Research
26.3 Microfluidics Market 2023-2030 ($M) - Regional Industry Research
26.4 Molecular Diagnostics Market 2023-2030 ($M) - Regional Industry Research
26.5 Immunoassay Market 2023-2030 ($M) - Regional Industry Research
27.MENA Point-Of-Care Diagnostics Market, By Prescription Mode Market 2023-2030 ($M)
27.1 Prescription-Based Testing Market 2023-2030 ($M) - Regional Industry Research
27.2 Otc Testing Market 2023-2030 ($M) - Regional Industry Research
28.MENA Point-Of-Care Diagnostics Market, By End User Market 2023-2030 ($M)
28.1 Professional Diagnostic Center Market 2023-2030 ($M) - Regional Industry Research
28.1.1 Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Setting Market 2023-2030 ($M)
28.1.2 Hospitals/Critical Care Center Market 2023-2030 ($M)
28.2 Home Care Market 2023-2030 ($M) - Regional Industry Research
28.3 Research Laboratory Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
2.Canada Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
3.Mexico Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
4.Brazil Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
5.Argentina Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
6.Peru Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
7.Colombia Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
8.Chile Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
9.Rest of South America Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
10.UK Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
11.Germany Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
12.France Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
13.Italy Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
14.Spain Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
16.China Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
17.India Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
18.Japan Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
19.South Korea Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
20.South Africa Point-of-Care/Rapid Diagnostics Market Revenue, 2023-2030 ($M)
21.North America Point-of-Care/Rapid Diagnostics By Application
22.South America Point-of-Care/Rapid Diagnostics By Application
23.Europe Point-of-Care/Rapid Diagnostics By Application
24.APAC Point-of-Care/Rapid Diagnostics By Application
25.MENA Point-of-Care/Rapid Diagnostics By Application
26.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Accubiotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Becton, Dickinson, And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Chembio Diagnostics, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Danaher Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Ekf Diagnostics, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Instrumentation Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Johnson & Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Nova Biomedical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Pt Diagnostics, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Quidel, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Roche Diagnostics, Sales /Revenue, 2015-2018 ($Mn/$Bn)
38.Sekisui Diagnostics, Sales /Revenue, 2015-2018 ($Mn/$Bn)
39.Siemens, Sales /Revenue, 2015-2018 ($Mn/$Bn)
40.Trinity Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)

The Point of Care Diagnostics Market is projected to grow at 9.7% CAGR during the forecast period 2025-2031.

The Point of Care Diagnostics Market size is estimated to be $xx Billion in 2024 and is projected to reach $25 Billion by 2031

The leading players in the Point of Care Diagnostics Market are Point of Care Diagnostics Market are Abbott Laboratories, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Danaher Corporation, Becton, Dickinson and Company and Others.